347 related articles for article (PubMed ID: 32316192)
1. Mitochondrial Protection by PARP Inhibition.
Gallyas F; Sumegi B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316192
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
3. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome.
Tapodi A; Bognar Z; Szabo C; Gallyas F; Sumegi B; Hocsak E
Biochem Pharmacol; 2019 Apr; 162():98-108. PubMed ID: 30296409
[TBL] [Abstract][Full Text] [Related]
4. Insights into the functional aspects of poly(ADP-ribose) polymerase-1 (PARP-1) in mitochondrial homeostasis in Dictyostelium discoideum.
Kadam A; Jubin T; Roychowdhury R; Garg A; Parmar N; Palit SP; Begum R
Biol Cell; 2020 Aug; 112(8):222-237. PubMed ID: 32324907
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.
Tapodi A; Debreceni B; Hanto K; Bognar Z; Wittmann I; Gallyas F; Varbiro G; Sumegi B
J Biol Chem; 2005 Oct; 280(42):35767-75. PubMed ID: 16115861
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.
Krainz T; Lamade AM; Du L; Maskrey TS; Calderon MJ; Watkins SC; Epperly MW; Greenberger JS; Bayır H; Wipf P; Clark RSB
ACS Chem Biol; 2018 Oct; 13(10):2868-2879. PubMed ID: 30184433
[TBL] [Abstract][Full Text] [Related]
7. A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats.
Magyar K; Deres L; Eros K; Bruszt K; Seress L; Hamar J; Hideg K; Balogh A; Gallyas F; Sumegi B; Toth K; Halmosi R
Biochim Biophys Acta; 2014 Jul; 1842(7):935-44. PubMed ID: 24657811
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol.
Szanto A; Hellebrand EE; Bognar Z; Tucsek Z; Szabo A; Gallyas F; Sumegi B; Varbiro G
Biochem Pharmacol; 2009 Apr; 77(8):1348-57. PubMed ID: 19426673
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway.
Hocsak E; Szabo V; Kalman N; Antus C; Cseh A; Sumegi K; Eros K; Hegedus Z; Gallyas F; Sumegi B; Racz B
Free Radic Biol Med; 2017 Jul; 108():770-784. PubMed ID: 28457938
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
11. Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury.
Casili G; Campolo M; Lanza M; Filippone A; Scuderi S; Messina S; Ardizzone A; Esposito E; Paterniti I
Mol Neurobiol; 2020 Nov; 57(11):4394-4407. PubMed ID: 32729104
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.
Rajawat J; Shukla N; Mishra DP
Med Res Rev; 2017 Nov; 37(6):1461-1491. PubMed ID: 28510338
[TBL] [Abstract][Full Text] [Related]
13. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.
Kalmar-Nagy K; Degrell P; Szabo A; Sumegi K; Wittmann I; Gallyas F; Sumegi B
PLoS One; 2013; 8(12):e81928. PubMed ID: 24312605
[TBL] [Abstract][Full Text] [Related]
15. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
Kang YH; Yi MJ; Kim MJ; Park MT; Bae S; Kang CM; Cho CK; Park IC; Park MJ; Rhee CH; Hong SI; Chung HY; Lee YS; Lee SJ
Cancer Res; 2004 Dec; 64(24):8960-7. PubMed ID: 15604259
[TBL] [Abstract][Full Text] [Related]
16. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
17. 3-aminobenzamide, one of poly(ADP-ribose)polymerase-1 inhibitors, rescuesapoptosisin rat models of spinal cord injury.
Meng X; Song W; Deng B; Xing Z; Zhang W
Int J Clin Exp Pathol; 2015; 8(10):12207-15. PubMed ID: 26722405
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
[TBL] [Abstract][Full Text] [Related]
20. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.
Thapa K; Khan H; Sharma U; Grewal AK; Singh TG
Life Sci; 2021 Feb; 267():118975. PubMed ID: 33387580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
